Prospective evaluation of planar bone scintigraphy, SPECT, SPECT/CT, <sup>18</sup>F-NaF PET/CT and whole body 1.5T MRI, including DWI, for the detection of bone metastases in high risk breast and prostate cancer patients: SKELETA clinical trial
Distribution of the number of citations over years.